First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Large Decrease in Short Interest

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 8,433 shares, a decrease of 77.9% from the November 30th total of 38,093 shares. Based on an average daily volume of 30,780 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the company’s shares are short sold. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 30,780 shares, the short-interest ratio is presently 0.3 days.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.4%

Shares of FBT traded down $0.94 during mid-day trading on Friday, reaching $214.13. The company had a trading volume of 6,665 shares, compared to its average volume of 20,843. First Trust NYSE Arca Biotechnology Index Fund has a fifty-two week low of $141.38 and a fifty-two week high of $215.83. The firm has a fifty day simple moving average of $203.30 and a 200-day simple moving average of $182.28. The stock has a market cap of $1.30 billion, a price-to-earnings ratio of 21.72 and a beta of 0.65.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after buying an additional 158 shares during the last quarter. Rossby Financial LCC lifted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 160.0% in the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after acquiring an additional 104 shares in the last quarter. Capital Investment Advisory Services LLC boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 63.1% in the third quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock valued at $32,000 after purchasing an additional 70 shares during the last quarter. Hazlett Burt & Watson Inc. grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 101.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 201 shares of the company’s stock valued at $36,000 after purchasing an additional 101 shares in the last quarter. Finally, Founders Financial Alliance LLC acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 3rd quarter valued at approximately $61,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.